Evidence for association between hepatitis C virus and Parkinson’s disease

@article{Abushouk2017EvidenceFA,
  title={Evidence for association between hepatitis C virus and Parkinson’s disease},
  author={A. Abushouk and Mostafa Wanees Ahmed El-Husseny and Mayar Magdy and Ammar Ismail and Attia Attia and Hussien Ahmed and Ravikishore Pallanti and Ahmed Negida},
  journal={Neurological Sciences},
  year={2017},
  volume={38},
  pages={1913-1920}
}
Parkinson’s disease (PD) is a globally prevalent neurodegenerative disorder, characterized by progressive neuronal loss in the substantia nigra and formation of Lewy bodies. These pathological characteristics are clinically translated into motor symptoms, such as bradykinesia, rigidity, resting tremors, and postural instability. Emerging data from epidemiological studies suggest a possible association between PD and hepatitis C virus (HCV) infection, which affects up to 71 million individuals… Expand
Microbial Infections Are a Risk Factor for Neurodegenerative Diseases
TLDR
The molecular and cellular mechanisms through which microbial infections may increase susceptibility to neurodegenerative diseases are discussed and elucidating these mechanisms is critical for developing targeted therapeutic approaches that prevent the onset and slow the progression of neurodegening diseases. Expand
Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection.
TLDR
Evidence suggested that the PD incidence was lower in patients with chronic HCV infection who received interferon-based antiviral therapy; this finding may support the hypothesis that HCV could be a risk factor for PD. Expand
Association between viral hepatitis infection and Parkinson's disease: A population‐based prospective study
TLDR
The findings suggest that adult patient of 40 years and older with HBV and HCV infections should be monitored for signs of Parkinson's disease so that early intervention and accurate treatment can be provided for minimizing the development and consequences of Parkinson’s disease. Expand
Refinement of the MPTP model for Parkinson’s disease in the marmoset
TLDR
Finetuning of the MPTP-induction protocol may improve the wellbeing of the animal and development of rational, effective treatments for the multi-factorial pathogenic mechanisms of PD. Expand
Association of variants in microRNA with Parkinson’s disease in Chinese Han population
TLDR
A case-control study of PD patients and healthy controls to genotype the two single-nucleotide polymorphisms (SNPs) showed that rs897984 and rs11651671 were not associated to PD, which suggest they may not contribute to the gene susceptibility of PD at least in Chinese Han population. Expand
Association of Antiviral TherapyWith Risk of Parkinson Disease in PatientsWith Chronic Hepatitis C Virus Infection
DESIGN, SETTING, AND PARTICIPANTS This cohort study obtained claims data from the Taiwan National Health Insurance Research Database. Adult patients with a new HCV diagnosis with or without hepatitisExpand
Epidemiology of Parkinson's Disease—East Versus West
TLDR
This review of epidemiological studies from East and West with an aim to observe the important similarities and differences in the disease occurrence and risk factor profile. Expand
Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis.
TLDR
The 12-week regimen of sofosbuvir plus velpatasvir was highly effective in HCV patients, including those with cirrhosis and former treatment experience, and except for genotype-3, adding ribavirin was not associated with significant improvements in SVR12 rates. Expand
Safety and Efficacy of Sofosbuvir plus Ledipasvir with and without Ribavirin for Chronic HCV Genotype-1 Infection: A Systematic Review and Meta-Analysis
TLDR
The combination of sofosbuvir and ledipasvir achieved high SVR rates (>90%) in both cirrhotic and non-cirrhotic patients with HCV genotype-1, and the addition of ribavirin to this regimen did not significantly increase theSVR rates. Expand
Application of a bioinformatic pipeline to RNA-seq data identifies novel viruslike sequence in human blood.
TLDR
A bioinformatic pipeline is developed that identifies microbial sequences in mammalian RNA-seq data, including sequences with no significant nucleotide similarity hits in GenBank, and identified sequences corresponding to known bacteria and viruses, as well as novel virus-like sequences. Expand
...
1
2
...

References

SHOWING 1-10 OF 65 REFERENCES
Hepatitis C virus infection: a risk factor for Parkinson's disease
TLDR
This study demonstrated a significantly positive epidemiological association between HCV infection and PD and corroborated the dopaminergic toxicity of HCV similar to that of MPP+. Expand
Association between hepatitis C virus infection and Parkinson's disease
TLDR
Hepatitis C virus (HCV)-induced neuroinflammation may lead to dopaminergic neuronal loss, suggesting a possible association between HCV infection and Parkinson’s disease (PD), which was investigated through a hospital-based, case-control study. Expand
Emerging evidence of hepatitis C virus neuroinvasion.
TLDR
Reports showing a close relationship between HCV sequences present in the brain and cerebrospinal fluid and sequences found in lymph nodes and peripheral blood mononuclear cells raise the possibility that HCV infection of the brain could be directly related to the reported neuropsychological and cognitive changes. Expand
Viral etiology for Parkinson's disease--a possible role of influenza A virus infection.
TLDR
It is proposed that neurovirulent influenza A virus and other potent viruses may be responsible for the formation of Lewy bodies and the later death of nigral neurons, to constitute a viral etiology for Parkinson's disease. Expand
Viral hepatitis and the risk of Parkinson disease
TLDR
It is imperative to focus research efforts on the search for the etiology of PD, as an outright definitive cure for the disease remains elusive, leaving both patients and their caregivers with the challenge of living with a chronic medical condition that affects their health-related quality of life. Expand
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
TLDR
The potential application of anti-inflammatory interventions in limiting the dopaminergic neuronal cell death in these models is discussed with evidence suggesting that the further investigation of their use as part of multi-targeted clinical trials is warranted. Expand
Molecular pathophysiology of Parkinson's disease.
TLDR
Increasing evidence indicates that deficits in mitochondrial function, oxidative and nitrosative stress, the accumulation of aberrant or misfolded proteins, and ubiquitin-proteasome system dysfunction may represent the principal molecular pathways or events that commonly underlie the pathogenesis of sporadic and familial forms of PD. Expand
Parkinson disease: from pathology to molecular disease mechanisms.
TLDR
Gene mutations identified in rare familial forms of PD encode proteins whose functions overlap widely with the known molecular pathways in sporadic disease and these have expanded knowledge of the neurodegenerative process but again have so far failed to yield effective models of sporadic disease when translated into animals. Expand
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
TLDR
Overall, available data support the importance of non-cell-autonomous pathological mechanisms in Parkinson's disease, which are mostly mediated by activated glial and peripheral immune cells. Expand
Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment
TLDR
Interestingly, patients with both decreased serotonin and dopamine transporter binding showed significantly impaired performance in most of the tests applied, indicating alteration of serotonergic and dopamine neurotransmission in HCV infected patients with chronic fatigue and cognitive impairment. Expand
...
1
2
3
4
5
...